Optician India

By:  Vinay Swaroop Balla

Navigating the 2050 Epidemiological Shift, Clinical Defocus Technologies, and the Paradigm Transition from Passive Dispensing to Proactive Pediatric Eyecare

1. The Looming Crisis: India’s Myopia Trajectory Toward 2050
For decades, optical dispensing in India has approached childhood refractive errors through a single lens: resolving immediate blur with standard single-vision spectacle lenses. However, global epidemiological data by the Brien Holden Vision Institute indicates an unprecedented global crisis: by 2050, more than 50% of the global population (5 billion people) will be myopic, with nearly 1 billion individuals categorized as high myopes (prescription over -5.00 D) [1].
India is progressing along an accelerated trajectory within this model. Urbanization, intensive educational pressures, prolonged screen time, and drastically curtailed outdoor activity have catalyzed a massive demographic surge. Longitudinal projections for urban Indian schoolchildren demonstrate an alarming ascent: prevalence jumped from 4.4% in 1999 to 21.1% in 2019 and is forecasted to reach 31.9% by 2030 and 48.1% by 2050.

The ocular hazard of progressing myopia is not refractive error itself, but the physical elongation of the eyeball (axial elongation).
Excessive axial stretching leads to severe lifelong pathologies:
Myopic Maculopathy: The leading cause of irreversible visual impairment in high myopes [3].
Retinal Detachment: Risk increases over 20-fold in patients with over -5.00 D compared to emmetropes [3]. Open-Angle Glaucoma & Early Subcapsular Cataract: Substantially elevated across all levels of myopia [3]. "Slowing myopia progression by just 1.00 D reduces the lifetime likelihood of a patient developing myopic maculopathy by approximately 40%. Every diopter counts in preserving long-term retinal integrity." - Bullimore & Brennan (2019).

2. The Optical Mechanism: Why Standard Lenses Accelerate Elongation
Traditional single-vision lenses correct central foveal vision perfectly but light rays entering the periphery of the eye come to a focus behind the peripheral retina, creating peripheral hyperopic defocus [5]. Many clinical trials have proven that this peripheral hyperopic blur acts as a potent biochemical stimulus signaling the eye to stretch / elongate backward.

3. Myopia Control Technologies in the Indian Market

The Indian ophthalmic market has witnessed the introduction of multiple evidence-based therapeutic lens technologies engineered with specialized lenslet or micro-element structures:

4. Indian Opticians: Current Perspectives vs. The Needed Paradigm Shift
Despite the scientific breakthrough of defocus optics, a significant execution gap remains across optical retail dispensaries in India. Opticians hold a uniquely influential position at the final point of care, yet current retail practices frequently hinder the widespread adoption of these sight-preserving lenses.
Current Retailing Obstacles

1. The "Premium Upsell" Trap: Positioning myopia control lenses alongside luxury coatings or premium lenses rather than treating them as an essential medical intervention.
2. Price Hesitancy & Assumption: Assuming parents will refuse premium therapeutic lenses, prompting staff to quote basic single-vision lenses to protect the immediate spectacle sale.
3. Lack of Follow-Up Protocols: Treating the sale as a one-time transactional purchase with no scheduled 6-month compliance reviews or axial length tracking.

Required Standard of Care

1. Default Clinical Recommendation: Presenting defocus lenses as the clinical baseline for any progressive myopic child under age 18
2. Value-Anchored Counselling: Framing lens cost over years of pathology prevention rather than comparing it against standard single-vision lenses.
3. Structured Care Protocols: Enforcing strict monocular pupillary centration, fitting parameters and structured 6-month recall reviews.

4. Precision Dispensing Protocols for Defocus Lenses

Dispensing defocus spectacle lenses is fundamentally different from dispensing single-vision or conventional progressive lenses. Because the lens contains treatment segments positioned around a small optical clear zone, even a 1-2 mm misalignment causes the child to look through the treatment zone in primary gaze, inducing peripheral distortions, visual discomfort and reducing clinical efficacy.

MANDATORY TECHNICAL DISPENSING CHECKLIST:

• Monocular Pupillometry: Measure monocular distance PD and mark the pupil center on the demo lens in the frame to measure the fitting height. Binocular averages are strictly prohibited.
• Fitting Height: Fit the optical center directly on the center of the pupil marked in primary gaze with natural head posture.
• Frame Geometry (B-size): Minimum vertical height of 28-30 mm to accommodate sufficient defocus zones.
• Vertex Distance & Pantoscopic Tilt: Maintain vertex distance between 10-12 mm and pantoscopic tilt between 0? to 5*

6. The Collaborative Triad: Ophthalmologist, Optometrist, and Optician
In the Indian eyecare ecosystem, patients frequently move between hospital clinics, independent optometrists, and retail optical stores. While the ophthalmologist or optometrist establishes the medical diagnosis through comprehensive eye examination and baseline counseling, the dispensing optician spends the maximum chair time with the parents exploring solutions.

Can customers be convinced by opticians?

Yes, absolutely. When an optician explains the underlying science using lens samples and connects the prescription to the prevention of high myopia complications, parent receptivity increases exponentially. The parent ceases to see an expensive pair of glasses and begins seeing a medical shield protecting their child’s vision.

7. Practical Dispensing Action Plan

• Reframing the Dialogue: Replace "Would you like standard lenses or the myopia control option?" with "For children whose prescription is rapidly progressing, clinical guidelines recommend defocus lenses to actively slow down eyeball elongation and protect future retinal health."
• Establishing Compliance Targets: Educate parents that clinical efficacy relies directly on wear time and that the children must regularly wear the defocus spectacles.
• The Complete Lifestyle Formula: Combine defocus spectacle wear with lifestyle and behavioral interventions - at least 120 minutes of daily outdoor activity with sunlight exposure and the 20-20-20 rule [10].

The prediction that nearly half of India’s urban youth could become myopic by 2050 is a formidable public health challenge. Indian opticians have an extraordinary opportunity to lead from the front line. By elevating professional dispensing standards, mastering accurate PD centration, and leading evidence-based counselling, opticians can transform from spectacle vendors into lifelong guardians of India's visual future.
REFERENCES

1. 1. Holden, B. A., Fricke, T. R., Wilson, D. A., et al. (2016). Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology, 123(5), 1036–1042.
   2. Priscilla, J. J., & Verkicharla, P. K. (2021). Myopia in India: Current Status and Future Projections (2020 –2050). Indian Journal of Ophthalmology, 69(11), 3131–3140.
   3. Flitcroft, D. I. (2012). The complex interactions of retinal, optical and environmental factors in myopia etiology. Progress in Retinal and Eye Research, 31(6), 622–660.
   4. Bullimore, M. A., & Brennan, N. A. (2019). Myopia Control: Why Each Diopter Matters. Optometry and Vision Science, 96(6), 463–465.
   5. Smith, E. L., 3rd, Kee, C. S., Ramamirtham, R., et al. (2005). Peripheral vision can influence eye growth and refractive development in infant monkeys. Investigative Ophthalmology & Visual Science, 46(11), 3965 –3972.
   6. Lam, C. S. Y., Tang, W. C., Tse, D. Y., et al. (2020). Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology, 104(3), 363–368.
   7. Bao, J., Yang, A., Huang, Y., et al. (2022). One-year myopia control efficacy of spectacle lenses with aspherical lenslets: results of a randomized, double-masked, clinical trial. British Journal of Ophthalmology, 106(8), 1161–1166.
   8. Liu, X., Wang, P., Xie, Z., et al. (2023). One-year myopia control efficacy of cylindrical annular refractive elements (C.A.R.E.) spectacle lenses in Chinese children. Journal of Clinical Ophthalmology & Research.
   9. Gwiazda, J., Hyman, L., Hussein, M., et al. (2003). A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Investigative Ophthalmology & Visual Science, 44(4), 1492 –1500.
   10. Gifford, K. L., Richdale, K., Kang, P., et al. (2019). IMI – Clinical Management Guidelines Report. Investigative Ophthalmology & Visual Science, 60(3), M184–M203.